Mass spectrometry-based proteomic profiling of lung cancer.
about
Proteomic-Based Approaches for the Study of Cytokines in Lung CancerAdvances in proteomic strategies toward the early detection of lung cancerDiscovery of new membrane-associated proteins overexpressed in small-cell lung cancer.Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.Identification of candidate biomarkers for early detection of human lung squamous cell cancer by quantitative proteomics.Mass spectrometry-based proteomics: the road to lung cancer biomarker discovery.Orthogonal organic and aqueous-based washes of tissue sections to enhance protein sensitivity by MALDI imaging mass spectrometry.Advances in tissue section preparation for MALDI imaging MS.The state of molecular biomarkers for the early detection of lung cancer.Identification of protein biomarkers and signaling pathways associated with prostate cancer radioresistance using label-free LC-MS/MS proteomic approach.Proteomic biomarkers in lung cancer.Current status of circulating protein biomarkers to aid the early detection of lung cancer.Comparative proteomic profiling of human lung adenocarcinoma cells (CL 1-0) expressing miR-372.Proteomic approaches for studying human parenchymal lung diseases.Significance of combined detection of LunX mRNA and tumor markers in diagnosis of lung carcinoma.Laboratory Medicine in the Scope of Proteomics and GenomicsOncogenic transformation of lung cells results in distinct exosome protein profile similar to the cell of origin.Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics.
P2860
Q26738539-29D1018A-C273-4C21-A703-AEE3CE715B2BQ31008766-16FBD551-00C0-4DA8-93C0-4BDD14D8C3E9Q33640246-2004918E-C81D-4F5B-B8A9-4BABCE07AA6BQ34030497-EAF19064-849E-4E2D-960F-5A58E14C8565Q34148738-92996FA0-1D92-401B-B389-6EC27D347372Q34350615-FD2D7787-BE8E-43D8-834F-FEAAF7112A7DQ34543350-D2BF7F2C-44D9-448F-8A1C-01A6431FE66DQ35164791-829C3657-6464-4D32-9F95-8C6E4C26CA0DQ37044593-B6A3845A-1BCA-4503-908D-4FD5BB3AA889Q37657753-38322991-CE88-4B15-9B4C-737FAEB9B8C7Q38100750-0E0DBC79-CA9A-4FE3-919A-C8874598BB84Q38232856-4A15703C-C40B-43B3-BC36-1C39ABD5DB52Q39373463-B2E48E20-8042-468B-B869-CAF9508A9088Q39927233-EBE4DA76-0743-4BF5-82F9-6D16A1F5E0E0Q41984458-6EE23FAC-EC99-4E71-8D18-922C882A52DDQ42378646-25CBD058-8D3A-4CAB-B8E7-BCF6977ABA47Q50882414-0A25F798-5CEA-42C0-A4E8-DC0182A32716Q54962725-A6AC071E-7A65-4C5D-9B1D-AEBAC7F7CC61
P2860
Mass spectrometry-based proteomic profiling of lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mass spectrometry-based proteomic profiling of lung cancer.
@en
Mass spectrometry-based proteomic profiling of lung cancer.
@nl
type
label
Mass spectrometry-based proteomic profiling of lung cancer.
@en
Mass spectrometry-based proteomic profiling of lung cancer.
@nl
prefLabel
Mass spectrometry-based proteomic profiling of lung cancer.
@en
Mass spectrometry-based proteomic profiling of lung cancer.
@nl
P2093
P2860
P1476
Mass spectrometry-based proteomic profiling of lung cancer.
@en
P2093
Pierre Chaurand
Pierre P Massion
Sebahat Ocak
P2860
P304
P356
10.1513/PATS.200809-108LC
P577
2009-04-01T00:00:00Z